Gundogdu, E.; Demir, E.-S.; Ekinci, M.; Ozgenc, E.; Ilem-Ozdemir, D.; Senyigit, Z.; Gonzalez-Alvarez, I.; Bermejo, M.
An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies. Nanomaterials 2022, 12, 250.
https://doi.org/10.3390/nano12020250
AMA Style
Gundogdu E, Demir E-S, Ekinci M, Ozgenc E, Ilem-Ozdemir D, Senyigit Z, Gonzalez-Alvarez I, Bermejo M.
An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies. Nanomaterials. 2022; 12(2):250.
https://doi.org/10.3390/nano12020250
Chicago/Turabian Style
Gundogdu, Evren, Emine-Selin Demir, Meliha Ekinci, Emre Ozgenc, Derya Ilem-Ozdemir, Zeynep Senyigit, Isabel Gonzalez-Alvarez, and Marival Bermejo.
2022. "An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies" Nanomaterials 12, no. 2: 250.
https://doi.org/10.3390/nano12020250
APA Style
Gundogdu, E., Demir, E.-S., Ekinci, M., Ozgenc, E., Ilem-Ozdemir, D., Senyigit, Z., Gonzalez-Alvarez, I., & Bermejo, M.
(2022). An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies. Nanomaterials, 12(2), 250.
https://doi.org/10.3390/nano12020250
